# The Effects of Inhaled Aclidinium Bromide/Formoterol Fumarate on Inspiratory Pleural Pressures in Smokers

> **NCT03104634** · PHASE3 · COMPLETED · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 43 (actual)

## Conditions studied

- Smoking

## Interventions

- **DRUG:** Aclidinium bromide/formoterol fumarate dihydrate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03104634
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-01
- **Primary completion:** 2018-12-01
- **Final completion:** 2019-02-01
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2019-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03104634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03104634, "The Effects of Inhaled Aclidinium Bromide/Formoterol Fumarate on Inspiratory Pleural Pressures in Smokers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03104634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*